vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and TSS, Inc. (TSSI). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $60.9M, roughly 1.4× TSS, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 20.0%, a 2.8% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 21.8%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $15.8M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 95.8%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
FDMT vs TSSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $60.9M |
| Net Profit | $19.4M | $12.2M |
| Gross Margin | — | 17.6% |
| Operating Margin | 17.3% | 1.5% |
| Net Margin | 22.8% | 20.0% |
| Revenue YoY | 8508900.0% | 21.8% |
| Net Profit YoY | 139.1% | 535.7% |
| EPS (diluted) | $0.43 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $60.9M | ||
| Q3 25 | $90.0K | $41.9M | ||
| Q2 25 | $15.0K | $44.0M | ||
| Q1 25 | $14.0K | $99.0M | ||
| Q4 24 | $1.0K | $50.0M | ||
| Q3 24 | $3.0K | $70.1M | ||
| Q2 24 | $5.0K | $12.2M | ||
| Q1 24 | $28.0K | $15.9M |
| Q4 25 | $19.4M | $12.2M | ||
| Q3 25 | $-56.9M | $-1.5M | ||
| Q2 25 | $-54.7M | $1.5M | ||
| Q1 25 | $-48.0M | $3.0M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $-43.8M | $2.6M | ||
| Q2 24 | $-35.0M | $1.4M | ||
| Q1 24 | $-32.4M | $15.0K |
| Q4 25 | — | 17.6% | ||
| Q3 25 | — | 11.1% | ||
| Q2 25 | — | 17.8% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 14.4% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 37.3% | ||
| Q1 24 | — | 17.1% |
| Q4 25 | 17.3% | 1.5% | ||
| Q3 25 | -67983.3% | -2.2% | ||
| Q2 25 | -396373.3% | 5.1% | ||
| Q1 25 | -383007.1% | 4.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | -1704400.0% | 5.4% | ||
| Q2 24 | -849120.0% | 14.0% | ||
| Q1 24 | -136200.0% | 1.6% |
| Q4 25 | 22.8% | 20.0% | ||
| Q3 25 | -63195.6% | -3.6% | ||
| Q2 25 | -364386.7% | 3.4% | ||
| Q1 25 | -342657.1% | 3.0% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | -1461433.3% | 3.8% | ||
| Q2 24 | -699060.0% | 11.5% | ||
| Q1 24 | -115717.9% | 0.1% |
| Q4 25 | $0.43 | $0.44 | ||
| Q3 25 | $-1.01 | $-0.06 | ||
| Q2 25 | $-0.98 | $0.06 | ||
| Q1 25 | $-0.86 | $0.12 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | $-0.79 | $0.10 | ||
| Q2 24 | $-0.63 | $0.06 | ||
| Q1 24 | $-0.66 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $85.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $76.6M |
| Total Assets | $566.7M | $184.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $85.5M | ||
| Q3 25 | $305.1M | $70.7M | ||
| Q2 25 | $293.2M | — | ||
| Q1 25 | $321.4M | — | ||
| Q4 24 | $424.9M | $23.2M | ||
| Q3 24 | $501.9M | $46.4M | ||
| Q2 24 | $541.9M | $8.3M | ||
| Q1 24 | $525.9M | $14.4M |
| Q4 25 | $505.7M | $76.6M | ||
| Q3 25 | $369.0M | $63.4M | ||
| Q2 25 | $420.9M | $9.5M | ||
| Q1 25 | $469.7M | $9.4M | ||
| Q4 24 | $510.6M | $7.1M | ||
| Q3 24 | $552.9M | $7.7M | ||
| Q2 24 | $588.3M | $5.2M | ||
| Q1 24 | $600.6M | $3.7M |
| Q4 25 | $566.7M | $184.9M | ||
| Q3 25 | $424.0M | $165.4M | ||
| Q2 25 | $473.6M | $139.5M | ||
| Q1 25 | $515.7M | $113.5M | ||
| Q4 24 | $560.4M | $96.6M | ||
| Q3 24 | $604.0M | $67.3M | ||
| Q2 24 | $620.1M | $28.9M | ||
| Q1 24 | $629.9M | $26.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $16.3M |
| Free Cash FlowOCF − Capex | $28.5M | $15.8M |
| FCF MarginFCF / Revenue | 33.5% | 25.9% |
| Capex IntensityCapex / Revenue | 0.1% | 0.9% |
| Cash ConversionOCF / Net Profit | 1.47× | 1.34× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $16.3M | ||
| Q3 25 | $-46.5M | $-18.4M | ||
| Q2 25 | $-43.4M | $16.3M | ||
| Q1 25 | $-47.8M | $20.6M | ||
| Q4 24 | $-134.6M | $-21.6M | ||
| Q3 24 | $-29.4M | $38.6M | ||
| Q2 24 | $-30.2M | $-4.3M | ||
| Q1 24 | $-29.1M | $2.6M |
| Q4 25 | $28.5M | $15.8M | ||
| Q3 25 | $-46.6M | $-24.9M | ||
| Q2 25 | $-43.4M | $5.4M | ||
| Q1 25 | $-48.4M | $5.8M | ||
| Q4 24 | $-138.4M | $-28.4M | ||
| Q3 24 | $-31.2M | $38.6M | ||
| Q2 24 | $-30.6M | $-6.0M | ||
| Q1 24 | $-29.8M | $2.6M |
| Q4 25 | 33.5% | 25.9% | ||
| Q3 25 | -51765.6% | -59.3% | ||
| Q2 25 | -289620.0% | 12.3% | ||
| Q1 25 | -345635.7% | 5.8% | ||
| Q4 24 | -13837100.0% | -56.7% | ||
| Q3 24 | -1038966.7% | 55.1% | ||
| Q2 24 | -611840.0% | -49.4% | ||
| Q1 24 | -106421.4% | 16.4% |
| Q4 25 | 0.1% | 0.9% | ||
| Q3 25 | 101.1% | 15.3% | ||
| Q2 25 | 440.0% | 24.8% | ||
| Q1 25 | 4507.1% | 15.0% | ||
| Q4 24 | 378600.0% | 13.4% | ||
| Q3 24 | 59266.7% | 0.1% | ||
| Q2 24 | 6980.0% | 13.8% | ||
| Q1 24 | 2535.7% | 0.2% |
| Q4 25 | 1.47× | 1.34× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 11.02× | ||
| Q1 25 | — | 6.93× | ||
| Q4 24 | — | -11.32× | ||
| Q3 24 | — | 14.60× | ||
| Q2 24 | — | -3.09× | ||
| Q1 24 | — | 176.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
TSSI
| Procurement Revenues Segment | $43.2M | 71% |
| System Integration Services Segment | $14.2M | 23% |
| Facilities Segment | $3.5M | 6% |
